- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 109.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 102.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 84.71M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $106.53M |
| Capex | Q1 2026 · Mar 31, 2025 | $57.61M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $71.99M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $16.45M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.08B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $937.72M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $185.39M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $200.39M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $288.54M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $248.43M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.21B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.98B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $432.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $564.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.86B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.87B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $567.99M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $511.36M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.17B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.94B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $3.12B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.42 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.42 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $42.13M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $29.07M |
| Net Income | Q1 2026 · Mar 31, 2026 | $44.08M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$81.98M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $86.03M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$100.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $376.55M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $272.5M |